Farallon Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $287K | Hold |
1,000
| – | – | ﹤0.01% | 97 |
|
|
2025
Q1 | $308K | Hold |
1,000
| – | – | ﹤0.01% | 100 |
|
|
2024
Q4 | $353K | Hold |
1,000
| – | – | ﹤0.01% | 98 |
|
|
2024
Q3 | $358K | Sell |
1,000
-142,000
| -99% | -$50.9M | ﹤0.01% | 110 |
|
|
2024
Q2 | $45.6M | Buy |
143,000
+33,000
| +30% | +$10.5M | 0.2% | 57 |
|
|
2024
Q1 | $25.3M | Sell |
110,000
-366,000
| -77% | -$84.1M | 0.11% | 63 |
|
|
2023
Q4 | $105M | Buy |
+476,000
| New | +$105M | 0.48% | 44 |
|
|
2023
Q3 | – | Sell |
-193,267
| Closed | -$42.7M | – | 175 |
|
|
2023
Q2 | $42.7M | Sell |
193,267
-471,500
| -71% | -$104M | 0.21% | 69 |
|
|
2023
Q1 | $149M | Buy |
664,767
+8,894
| +1% | +$1.99M | 0.81% | 40 |
|
|
2022
Q4 | $182M | Buy |
655,873
+106,200
| +19% | +$29.5M | 1.08% | 33 |
|
|
2022
Q3 | $115M | Buy |
549,673
+156,977
| +40% | +$32.9M | 0.63% | 47 |
|
|
2022
Q2 | $92.5M | Buy |
392,696
+13,000
| +3% | +$3.06M | 0.5% | 53 |
|
|
2022
Q1 | $68.1M | Buy |
379,696
+58,936
| +18% | +$10.6M | 0.33% | 63 |
|
|
2021
Q4 | $69.3M | Buy |
+320,760
| New | +$69.3M | 0.35% | 54 |
|
|
2020
Q3 | – | Sell |
-350,000
| Closed | -$42.4M | – | 135 |
|
|
2020
Q2 | $42.4M | Sell |
350,000
-15,000
| -4% | -$1.82M | 0.34% | 62 |
|
|
2020
Q1 | $34.6M | Buy |
+365,000
| New | +$34.6M | 0.3% | 50 |
|